These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6494585)

  • 21. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
    Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F
    Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE
    Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines.
    Miller MA; Katzenellenbogen BS
    Cancer Res; 1983 Jul; 43(7):3094-100. PubMed ID: 6850618
    [No Abstract]   [Full Text] [Related]  

  • 24. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S; Saxena N; Sengupta K; Tawfik O; Mayo MS; Banerjee SK
    Neoplasia; 2003; 5(1):63-73. PubMed ID: 12659671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS; Pink JJ; Jordan VC
    Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T; Shibata J; Nukatsuka M; Yamada Y
    Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
    Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between proliferative activity and cellular hormono-dependence in the MCF-7 breast cancer cell line.
    del Moral R; Ruiz de Almodóvar JM; Fernández JC; López-González JD; Villalba J; Olea N; Pedraza V
    Rev Esp Fisiol; 1990 Sep; 46(3):247-53. PubMed ID: 1965340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
    Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and progesterone receptors in human breast cancer.
    Seckinger D
    J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
    [No Abstract]   [Full Text] [Related]  

  • 32. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness.
    Whitehead RH; Quirk SJ; Vitali AA; Funder JW; Sutherland RL; Murphy LC
    J Natl Cancer Inst; 1984 Sep; 73(3):643-8. PubMed ID: 6381852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiestrogenic effects of LY 117018 in MCF-7 cells.
    Scholl SM; Huff KK; Lippman ME
    Endocrinology; 1983 Aug; 113(2):611-7. PubMed ID: 6872943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
    Sirbasku DA; Moreno-Cuevas JE
    In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness.
    Fernandez P; Burghardt R; Smith R; Nodland K; Safe S
    Eur J Pharmacol; 1994 Jan; 270(1):53-65. PubMed ID: 8157081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pure antiestrogens. Mode of action and therapeutic prospects.
    Wakeling AE
    Ann N Y Acad Sci; 1990; 595():348-56. PubMed ID: 2375612
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological response of the anti-estrogen ICI 164,384 in human hormone-dependent and hormone-independent mammary cancer cell lines.
    Pasqualini JR; Gelly C
    Cancer Lett; 1990 Apr; 50(2):133-9. PubMed ID: 2328482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.